Oran, Betül
Champlin, Richard E. http://orcid.org/0000-0002-4314-5037
Wang, Feng
Tanaka, Tomoyuki
Saliba, Rima M.
Al-Atrash, Gheath
Garcia-Manero, Guillermo http://orcid.org/0000-0002-3631-2482
Kantarjian, Hagop http://orcid.org/0000-0002-1908-3307
Cao, Kai
Shpall, Elizabeth J.
Alousi, Amin M. http://orcid.org/0000-0002-2498-8573
Mehta, Rohtesh S.
Popat, Uday http://orcid.org/0000-0002-7592-2224
Futreal, Andy http://orcid.org/0000-0001-8663-2671
Takahashi, Koichi http://orcid.org/0000-0002-8027-9659
Article History
Received: 11 January 2021
Revised: 19 May 2021
Accepted: 26 May 2021
First Online: 16 June 2021
Change Date: 7 December 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41375-021-01430-y
COMPETING INTERESTS
: BO has received research funding from ASTEX Pharmaceuticals and AROG Pharmaceuticals. KT has been on the advisory boards of Symbio Pharmaceuticals, Novartis, Celgene, and GSK. All other authors declare no competing interests.